Skip to main content

Resource Center

Filters
Select resource types
Select products & services
Select solutions (2)
Active filters (2)
Clear all
241 - 252 of 313 Results
Sort by: Best match
Best match
Title A-Z
Title Z-A
Filter & sort
Infographic Icon   Infographic
Ditch the wash steps and accelerate discovery
ELISA immunoassays are great, but what if you could improve sensitivity and increase dynamic range all while eliminating wash steps and saving time?
Flyer Icon   Flyer
High-quality microplates for storage StorPlate™
Discover Revvity's StorPlate™ microplates designed for optimal compound storage. Made from solvent-resistant polypropylene, these plates are suitable for temperatures down to -80°C and are DNAse, RNAse, and pyrogen free. Available in various well configurations, including U-bottom, V-bottom, and deep-well options, ensuring maximum volume and protection for your samples. Learn more about our high-quality storage solutions at Revvity.
Application Note Icon   Application Note
Evaluating the specificity of PD-1 and PD-L1 blocking antibodies using AlphaLISA human and mouse PD-1/PD-L1 binding kits
Find out how the AlphaLISA human/mouse PD-1/PD-L1 binding assays provide a fast, powerful, homogeneous platform for obtain binding potencies from potential novel drug candidates.
Application Note Icon   Application Note
Fc-Receptor binding ADCC assays utilizing AlphaLISA technology: Characterization of hIgGs and FcγRIIIa
This application note demonstrates how AlphaLISA assay can be used to determine the binding activity of human IgG Fc fragment to human FcγRIIIa and to study how other antibodies bind to FcγRIIIa.
Application Note Icon   Application Note
Utilization of AlphaLISA technology to accurately detect asthma biomarkers in human serum
In this application note, AlphaLISA technology was used to quantify biomarker levels in serum samples, specifically Human IL-21, IL-33, and TNFα.
Brochure Icon   Brochure
Biologics workflow solutions
Revvity can help you discover and develop high-quality biological drug products by streamlining the biologics workflow.
Publication Icon   Literature - Publication Review
Current approaches to identify possible COVID-19 therapeutics
Current approaches to identify possible COVID-19 treatment strategies fall into one of three categories: Antivirals, antibodies, or protein-protein interaction inhibitors.
Whitepaper Icon   Whitepaper
An emerging therapeutic modality - RNA carves its path out of the paradigm
Learn more about several promising classes of RNA therapeutic, including RNAi, CRISPR, base editing, and mRNA vaccines, as well as the potential to combine RNA technologies with CAR-T.
Application Note Icon   Application Note
Guidelines for optimization of a cell-labelling method for DELFIA-TRF cytotoxicity assays.
Discover expert guidelines for optimizing cell labeling in DELFIA TRF cytotoxicity assays. Learn how to enhance assay performance, manage spontaneous release, and achieve accurate results with this comprehensive application note.
Application Note Icon   Application Note
RNA yield RIN mouse tissues - preservation extraction comparison
Comparison of RNA extraction results from mouse tissues using different preservation and extraction parameters via bead beating without cryogenic conditions.
Application Note Icon   Application Note
Streamlining the development of bispecific antibodies from expression to quality assessment with Revvity’s biotherapeutic workflow solutions
Expression and characterization of bispecific antibodies with a combination of CHOSOURCE TnT Transposon Technology and LabChip to streamline biotherapeutic workflows
Application Note Icon   Application Note
Vascular imaging probes for oncology and inflammation
IVISense™ vascular fluorescent probes for studying oncology and inflammation using the IVIS® preclinical imaging platform
resource-center-page-end-card-bg-illuminator.png
resource-center-page-end-card-bg-illuminator-mobile.png

Looking for technical documents?

Find the technical documents you need, ASAP, in our easy-to-search library.